English | Español
Robert Hadley | Apr 5, 2017

European Commission OKs Pfizer’s Xeljanz for rheumatoid arthritis treatment
Erianne Leatherman | Apr 5, 2017

BMS, Foundation Medicine partner on predictive biomarker project
Robert Hadley | Apr 5, 2017

Pharma spinoff AbbVie joins network to share oncology outcomes
Robert Hadley | Apr 5, 2017

Immunotherapy drug approved for U.S. patients
Erianne Leatherman | Apr 5, 2017

Sanofi Genzyme expands Multiple Myeloma Journey Partners program

Erianne Leatherman | Apr 3, 2017

Symproic receives approval with U.S. launch expected this summer

Ruth de Jauregui | Apr 3, 2017

European Medicines Agency recommends Keytruda for approval
Kyle Perrotti | Apr 3, 2017

New algorithm could help EMS determine best hospital for treatment of stroke

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’